Back to Stakeholders
Care Delivery & Psychedelic FacilitationClinical Care Delivery OrganizationsHealth Systems & Hospitals
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchSpecialized Academic Departments and Institutes
Care Delivery & Psychedelic FacilitationClinical Care Delivery Organizations
Care Delivery & Psychedelic Facilitation
Research, Drug Development & Manufacturing

Centre Hospitalier Universitaire de Charleroi

Belgium
6 Trials

University hospital in Charleroi, Belgium affiliated with the Université Libre de Bruxelles. Participates in clinical trials for psychiatric and neurological conditions, including studies in the emerging area of esketamine and rapid-acting antidepressant therapies.

Academic Research

0 papers

Published Papers

0

Trial Involvement

6

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
Other
HQ
Belgium
Website
Visit

Sponsored Trials

4
CompletedNA

Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression (PSILODAC)

Start Date
Compounds
Psilocybin
CompletedNA

Evaluation of the Effect of a Single Dose of Psilocybin on Neural Correlates of Cognitive Control in Patients with Psychogenic Nonepileptic Seizures (CRIPSY)

Start Date
Compounds
Psilocybin
CompletedNA

Psilocybin in Alcohol Use Disorder With Comorbid Depression (PAD)

Start Date
Compounds
Psilocybin
Unknown statusNA

Comparison of Ketamine and Esketamine in Patients Suffering From Fibromyalgia Syndrome

Start Date
Compounds
Ketamine, Esketamine

Collaborated Trials

2
RecruitingII, III

Ketamine to Treat Patients With Post-comatose Disorders of Consciousness

Start Date
Compounds
Ketamine, Placebo
RecruitingI, II

Psilocybin for Psychological and Existential Distress in Palliative Care

Start Date
Compounds
Psilocybin